Skip to main content

Welkom bij Scalda & Bohn Stafleu van Loghum

Scalda heeft ervoor gezorgd dat je Mijn BSL eenvoudig en snel kunt raadplegen.Je kunt de producten hieronder links aanschaffen en rechts inloggen.

Registreer

Schaf de BSL Academy aan: 

BSL Academy mbo AG

Eenmaal aangeschaft kun je thuis, of waar ook ter wereld toegang krijgen tot Mijn BSL.

Heb je een vraag, neem dan contact op met Jan van der Velden.

Login

Als u al geregistreerd bent, hoeft u alleen maar in te loggen om onbeperkt toegang te krijgen tot Mijn BSL.

Top
Gepubliceerd in:

26-10-2021

Testing the Effectiveness of Brief Behavioral Activation Treatment for Depression—Revised: Changes in Depression, Anxiety, Dysfunctional Attitudes, and Mindfulness

Auteurs: Jerin Lee, Cameron G. Ford, D. Lee McCluskey, Patricia D. Hopkins, Daniel W. McNeil, Natalie J. Shook

Gepubliceerd in: Journal of Psychopathology and Behavioral Assessment | Uitgave 2/2022

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

We tested the effectiveness of Brief Behavioral Activation Treatment for Depression-Revised (BATD-R), and its impact on secondary outcomes: anxiety, dysfunctional attitudes, and mindfulness. It was expected that individuals who completed BATD-R would exhibit decreased depression, anxiety, and dysfunctional attitudes, as well as increased mindfulness. A sample of adults with depression (n = 42) was recruited to complete the 10-week treatment. A healthy control group (n = 38) was included for comparison. Outcomes (depression, anxiety, dysfunctional attitudes, and mindfulness) were assessed at pre-treatment, post-treatment or 10 weeks for the healthy control group, and three-month follow-up. At pre-treatment, the clinical group reported greater depression, anxiety, and dysfunctional attitudes, and less mindfulness than the healthy control group. At post-treatment, the clinical group reported decreased depressive symptoms, trait anxiety, and dysfunctional attitudes, and increased mindfulness, compared to pre-treatment. The control group did not exhibit changes across the 10 weeks. Clinical and healthy control group post-treatment scores did not differ. At three-month follow-up, the clinical group reported a slight increase in depressive symptoms from post-treatment, but still maintained lower depressive symptoms than pre-treatment. The clinical group maintained treatment gains in dysfunctional attitudes, and mindfulness. Results support the effectiveness of BATD-R and suggest BATD-R may influence dysfunctional attitudes and mindfulness.
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Voetnoten
1
For individuals who indicated psychotropic medication usage, only those who were stabilized on their medication for six weeks were enrolled in the study.
 
2
As anxiety and depression are highly comorbid (Brown et al., 1998; Hranov, 2007), we ran analyses including each of the pre-treatment anxiety measures as a covariate. The pattern of results generally remained the same (see Supplemental Material).
 
3
The pattern of results remained the same when anxiety was included as a covariate (see Supplemental Material).
 
Literatuur
go back to reference Barlow, D. H. (2002). Anxiety and its disorders: The nature and treatment of anxiety and panic (2nd ed.). Guilford Press. Barlow, D. H. (2002). Anxiety and its disorders: The nature and treatment of anxiety and panic (2nd ed.). Guilford Press.
go back to reference Beck, A. T., Steer, R. A., & Brown, G. K. (1996). Manual for the Beck Depression Inventory-II. Psychological Corporation. Beck, A. T., Steer, R. A., & Brown, G. K. (1996). Manual for the Beck Depression Inventory-II. Psychological Corporation.
go back to reference Daughters, S. B., Braun, A. R., Sargeant, M. N., Reynolds, E. K., Hopko, D. R., Blanco, C., & Lejuez, C. W. (2008). Effectiveness of a brief behavioral treatment for inner-city illicit drug users with elevated depressive symptoms: The life enhancement treatment for substance use (LETS Act!). Journal of Clinical Psychiatry, 69, 122–129. https://doi.org/10.4088/jcp.v69n0116CrossRefPubMed Daughters, S. B., Braun, A. R., Sargeant, M. N., Reynolds, E. K., Hopko, D. R., Blanco, C., & Lejuez, C. W. (2008). Effectiveness of a brief behavioral treatment for inner-city illicit drug users with elevated depressive symptoms: The life enhancement treatment for substance use (LETS Act!). Journal of Clinical Psychiatry, 69, 122–129. https://​doi.​org/​10.​4088/​jcp.​v69n0116CrossRefPubMed
go back to reference First, M. B., Gibbon, M., Spitzer, R. L., Benjamin, L. S., & Williams, J. B. (1997). Structured Clinical Interview for DSM-IV® Axis II Personality Disorders SCID-II. American Psychiatric Publishing. First, M. B., Gibbon, M., Spitzer, R. L., Benjamin, L. S., & Williams, J. B. (1997). Structured Clinical Interview for DSM-IV® Axis II Personality Disorders SCID-II. American Psychiatric Publishing.
go back to reference Hopko, D. R., Armento, M. E., Robertson, S., Ryba, M. M., Carvalho, J. P., Colman, L. K., & Lejuez, C. W. (2011). Brief behavioral activation and problem-solving therapy for depressed breast cancer patients: Randomized trial. Journal of Consulting and Clinical Psychology, 79, 834–849. https://doi.org/10.1037/a0025450CrossRefPubMed Hopko, D. R., Armento, M. E., Robertson, S., Ryba, M. M., Carvalho, J. P., Colman, L. K., & Lejuez, C. W. (2011). Brief behavioral activation and problem-solving therapy for depressed breast cancer patients: Randomized trial. Journal of Consulting and Clinical Psychology, 79, 834–849. https://​doi.​org/​10.​1037/​a0025450CrossRefPubMed
go back to reference Judah, M. R., Dahne, J., Hershenberg, R., & Gros, D. F. (2020). Behavioral activation. In J. S. Abramowitz & S. M. Blakey (Eds.), Clinical handbook of fear and anxiety: Maintenance processes and treatment mechanisms (pp. 305–321). American Psychological Association. https://doi.org/10.1037/0000150-017 Judah, M. R., Dahne, J., Hershenberg, R., & Gros, D. F. (2020). Behavioral activation. In J. S. Abramowitz & S. M. Blakey (Eds.), Clinical handbook of fear and anxiety: Maintenance processes and treatment mechanisms (pp. 305–321). American Psychological Association. https://​doi.​org/​10.​1037/​0000150-017
go back to reference Martell, C. R., & Kanter, J. W. (2011). Behavioral activation in the context of “third wave” therapies. In J. D. Herbert & E. M. Forman (Eds.), Acceptance and mindfulness in cognitive behavior therapy: Understanding and applying the new therapies (pp. 193–209). John Wiley & Sons Inc. Martell, C. R., & Kanter, J. W. (2011). Behavioral activation in the context of “third wave” therapies. In J. D. Herbert & E. M. Forman (Eds.), Acceptance and mindfulness in cognitive behavior therapy: Understanding and applying the new therapies (pp. 193–209). John Wiley & Sons Inc.
go back to reference Ryba, M. M., Lejuez, C. W., & Hopko, D. R. (2014). Behavioral activation for depressed breast cancer patients: The impact of therapeutic compliance and quantity of activities completed on symptom reduction. Journal of Consulting and Clinical Psychology, 82, 325. https://doi.org/10.1037/a0035363CrossRefPubMed Ryba, M. M., Lejuez, C. W., & Hopko, D. R. (2014). Behavioral activation for depressed breast cancer patients: The impact of therapeutic compliance and quantity of activities completed on symptom reduction. Journal of Consulting and Clinical Psychology, 82, 325. https://​doi.​org/​10.​1037/​a0035363CrossRefPubMed
go back to reference Spielberger, C. D. (1983). State-Trait Anxiety Inventory for adults. Mind Garden. Spielberger, C. D. (1983). State-Trait Anxiety Inventory for adults. Mind Garden.
go back to reference Tull, M. T., Rosenblatt, C. B., Berghoff, C. R., Dixon, L. J., Ciarloni, E., Montgomery, D. D., & Marshall, G. D. (2019). An uncontrolled open trial of a Brief Behavioural Activation Treatment for Depression in patients with chronic spontaneous urticaria. Behaviour Change, 36, 75–83. https://doi.org/10.1017/bec.2019.5CrossRef Tull, M. T., Rosenblatt, C. B., Berghoff, C. R., Dixon, L. J., Ciarloni, E., Montgomery, D. D., & Marshall, G. D. (2019). An uncontrolled open trial of a Brief Behavioural Activation Treatment for Depression in patients with chronic spontaneous urticaria. Behaviour Change, 36, 75–83. https://​doi.​org/​10.​1017/​bec.​2019.​5CrossRef
Metagegevens
Titel
Testing the Effectiveness of Brief Behavioral Activation Treatment for Depression—Revised: Changes in Depression, Anxiety, Dysfunctional Attitudes, and Mindfulness
Auteurs
Jerin Lee
Cameron G. Ford
D. Lee McCluskey
Patricia D. Hopkins
Daniel W. McNeil
Natalie J. Shook
Publicatiedatum
26-10-2021
Uitgeverij
Springer US
Gepubliceerd in
Journal of Psychopathology and Behavioral Assessment / Uitgave 2/2022
Print ISSN: 0882-2689
Elektronisch ISSN: 1573-3505
DOI
https://doi.org/10.1007/s10862-021-09938-4